Comparison of Open-Label, 8-Week Trials of Olanzapine Monotherapy and Topiramate Augmentation of Olanzapine for the Treatment of Pediatric Bipolar Disorder-Reference-Cited by-同舟云学术

Comparison of Open-Label, 8-Week Trials of Olanzapine Monotherapy and Topiramate Augmentation of Olanzapine for the Treatment of Pediatric Bipolar Disorder

Published:2009-10 Issue:5 Volume:19 Page:539-545
ISSN:1044-5463
Container-title:Journal of Child and Adolescent Psychopharmacology
language:en
Short-container-title:Journal of Child and Adolescent Psychopharmacology

Author:

Wozniak Janet¹,Mick Eric¹,Waxmonsky James¹,Kotarski Meghan¹,Hantsoo Liisa¹,Biederman Joseph¹

Affiliation:

1. Pediatric Psychopharmacology Research Department, Massachusetts General Hospital, Department of Psychiatry at Harvard Medical School, Boston, Massachusetts.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Psychiatry and Mental health,Pediatrics, Perinatology, and Child Health

Link

http://www.liebertpub.com/doi/pdf/10.1089/cap.2009.0042

Reference40 articles.

1. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision (DSM-IV-TR)

2. Topiramate for Binge-Eating Disorder

3. Aripiprazole in the Treatment of Pediatric Bipolar Disorder: A Systematic Chart Review

4. Open-Label, 8-Week Trial of Olanzapine and Risperidone for the Treatment of Bipolar Disorder in Preschool-Age Children

5. An Open-Label Trial of Risperidone in Children and Adolescents with Bipolar Disorder

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Double-Blind, Placebo-Controlled Study of Adjunctive Topiramate in Adolescents With Co-Occurring Bipolar and Cannabis Use Disorders;JAACAP Open;2024-09

2. Advances in the management of bipolar disorder in children and adolescents: an update on the literature;Expert Review of Neurotherapeutics;2024-08-05

3. Pharmacological Treatment of Binge Eating Disorder and Frequent Comorbid Diseases;CNS Drugs;2024-08-03

4. TOPIRAMATE;Prescriber's Guide – Children and Adolescents;2024-05-02

5. Efficacy of topiramate in reducing second‐generation antipsychotic‐associated weight gain among children: A systematic review and meta‐analysis;Diabetes, Obesity and Metabolism;2024-03-13